Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
GPR88 Biologics Sequence Review Report 2026: G protein-coupled receptor 88 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR88 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPRASP3 Biologics Sequence Review Report 2026: G protein-coupled receptor associated sorting protein 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPRASP3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR82 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 82 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR82 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR85 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 85 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR85 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR84 Biologics Sequence Review Report 2026: G protein-coupled receptor 84 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR84 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR83 Biologics Sequence Review Report 2026: G protein-coupled receptor 83 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR83 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR65 Biologics Sequence Review Report 2026: G protein-coupled receptor 65 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR65 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR78 Biologics Sequence Review Report 2026: G protein-coupled receptor 78 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR78 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR75 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 75 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR75 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR68 Biologics Sequence Review Report 2026: G protein-coupled receptor 68 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR68 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ADAMTS4 Biologics Sequence Review Report 2026: A disintegrin and metalloproteinase with thrombospondin motifs 4 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of ADAMTS4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR45 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 45 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR45 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.